Back to Search Start Over

Fetal programming of COVID-19: may the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease?

Authors :
Gerosa C
Faa G
Fanni D
Manchia M
Suri JS
Ravarino A
Barcellona D
Pichiri G
Coni P
Congiu T
Piras M
Cerrone G
Cau F
Ledda F
Aimola V
Coghe F
Porcu M
Cau R
Orru' G
Van Eyken P
La Nasa G
Castagnola M
Marongiu F
Saba L
Source :
European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2021 Sep; Vol. 25 (18), pp. 5876-5884.
Publication Year :
2021

Abstract

The risk stratification of young adults between subjects who will develop a mild form COVID-19 and subjects who will undergo a severe disease remains inaccurate. In this review, we propose that the Barker hypothesis might explain the increased susceptibility to severe forms of COVID-19 in subjects who underwent intrauterine growth restriction (IUGR). In this paper evidence indicating an association between a low birth weight and an adult phenotype which might favor a severe outcome of SARS-CoV-2 infection are presented: lower lung functional capacity; increased respiratory morbidity; changes in fibrinogen and Factor VII serum levels and dysregulation of the hemostasis and thrombosis system; acquisition of a pro-thrombotic phenotype; low nephron number, with decreased ability to sustain renal function and increased renal morbidity; heart remodeling, with a less efficient cardiac function; endothelial dysfunction, a risk factor for the insurgence of the multiple organ failure; remodeling of arteries, with changes in the elastic properties of the arterial wall, predisposing to the insurgence and progression of atherosclerosis; dysfunction of the innate immune system, a risk factor for immune diseases in adulthood. These data suggest that young and adult subjects born too small (IUGR) or too early (pre-terms) might represent a subgroup of "at risk subjects", more susceptible toward severe forms of COVID-19. Given that LBW may be considered a surrogate of IUGR, this phenotypic marker should be included among the indispensable clinical data collected in every patient presenting with SARS-COV-2 infection, irrespectively of his/her age.

Details

Language :
English
ISSN :
2284-0729
Volume :
25
Issue :
18
Database :
MEDLINE
Journal :
European review for medical and pharmacological sciences
Publication Type :
Academic Journal
Accession number :
34604981
Full Text :
https://doi.org/10.26355/eurrev_202109_26810